Reshape Lifesciences Inc.
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Previously recorded as EnteroMedics Inc. (to 2018)
Previously recorded as Obalon Therapeutics, Inc. (to 2021)
19
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 2 to 25, 2026 · next Dec 2
- 3 fees due Jan 2 to 16, 2027 · next Jan 2
- 1 fee due Feb 22, 2027The maintenance fee for Systems and Methods for Determining Failure of Intragastric Devices (US 11,730,619) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
- 2 fees due May 3 to 21, 2027 · next May 3
- 1 fee due Jun 1, 2027The maintenance fee for Implantable Injection Port (US 9,199,069) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
- 1 fee due Jul 21, 2027The maintenance fee for Intragastric Device with Expandable Portions (US 10,537,453) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Intragastric Device System (US 10,617,545) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
- 1 fee due Nov 10, 2027The maintenance fee for Methods and Systems for Glucose Regulation (US 9,333,340) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,822,486 | Custom Sized Neural Electrodes In force · High confidence | In force | High confidence | |
| US 7,762,998 | Implantable Device Fastening System and Methods of Use In force · High confidence | In force | High confidence | |
| US RE47,902 | Method and Apparatus for Treating Obesity and Controlling Weight Gain Using Self-Expanding Intragastric Devices In force · Low confidence | In force | Low confidence | |
| US 9,333,340 | Methods and Systems for Glucose Regulation In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 9,974,955 | Methods and Systems for Glucose Regulation In force · High confidence | In force | High confidence | |
| US 10,722,714 | Methods and Systems for Glucose Regulation In force · High confidence | In force | High confidence | |
| US 8,409,221 | Implantable Access Port Device Having a Safety Cap In force · High confidence | In force | High confidence | |
| US 7,854,745 | Intragastric Device In force · High confidence | In force | High confidence | |
| US 8,162,969 | Intragastric Device In force · High confidence | In force | High confidence | |
| US 8,845,674 | Intragastric Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 53: 18 patents in force now held by others · 52 lapsed for an unpaid fee · 11 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 2 abandoned · 4 no status recorded